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Background: Syntaxins are a family of membrane proteins involved in vesicle trafficking, such as synaptic vesicle
exocytosis. Syntaxin 4 (Stx4) is expressed highly in skeletal muscle and plays a critical role in insulin-stimulated
glucose uptake by promoting translocation of glucose transporter 4 (GLUT4) to the cell surface. A cell surface
receptor cell adhesion molecule-related, down-regulated by oncogenes (Cdo) is a component of cell adhesion
complexes and promotes myoblast differentiation via activation of key signalings, including p38MAPK and AKT. In
this study, we investigate the function of Stx4 in myoblast differentiation and the crosstalk between Stx4 and Cdo
in myoblast differentiation.
Methods: The effects of overexpression or shRNA-based depletion of Stx4 and Cdo genes on C2C12 myoblast
differentiation are assessed by Western blotting and immunofluorescence approaches. The interaction between
Cdo and Stx4 and the responsible domain mapping are assessed by coimmunoprecipitation or pulldown assays.
The effect of Stx4 depletion on cell surface localization of Cdo and GLUT4 in C2C12 myoblasts is assessed by
surface biotinylation and Western blotting.
Results: Overexpression or knockdown of Stx4 enhances or inhibits myogenic differentiation, respectively. Stx4
binds to the cytoplasmic tail of Cdo, and this interaction seems to be critical for induction of p38MAPK activation
and myotube formation. Stx4 depletion decreases specifically the cell surface localization of Cdo without changes
in surface N-Cadherin levels. Interestingly, Cdo depletion reduces the level of GLUT4 and Stx4 at cell surface.
Consistently, overexpression of Cdo in C2C12 myoblasts generally increases glucose uptake, while Cdo depletion
reduces it.
Conclusions: Stx4 promotes myoblast differentiation through interaction with Cdo and stimulation of its surface
translocation. Both Cdo and Stx4 are required for GLUT4 translocation to cell surface and glucose uptake in
myoblast differentiation.
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Skeletal myoblast differentiation is a well-coordinated
multistep process that involves cell cycle withdrawal, ex-
pression of muscle-specific genes, and formation of multi-
nucleated myofibers by cell fusion [1]. Two groups of
transcription factors, the myogenic determination factors
(Myf5, MyoD, Myogenin, and MRF4) and the myocyte en-
hancer factor 2 (MEF2), are central for the coordination
of myogenesis [2–4]. The expression and activities of these
transcription factors are tightly regulated to ensure effi-
cient myogenic differentiation and to maintain the differ-
entiated state of cells. Once activated, these transcription
factors regulate numerous downstream target genes to ini-
tiate myogenic differentiation and reinforce each other’s
expression, resulting in a positive feedback network that
amplifies and maintains the myogenic phenotype [5, 6].
Cell-cell adhesion between muscle precursors plays a
crucial role in myoblast differentiation. A cell surface re-
ceptor cell adhesion molecule-related, down-regulated
by oncogenes (Cdo) appears to be a critical component
that integrates cell-contact-mediated signals from the
cell surface into the myogenic regulatory network [7, 8].
Cdo forms a multiprotein complex with other cell adhe-
sion molecules including N-Cadherin, Gas1, Boc, and
neogenin/netrin-3, resulting in the promotion of myo-
genesis [9–12]. The depletion of Cdo in myoblasts shows
impaired myogenic differentiation, and Cdo-deficient mice
display delayed skeletal muscle development [7, 13]. In
contrast, overexpression of Cdo in C2C12 cells enhances
myoblast differentiation. The promyogenic function of
Cdo involves a coordinated activation of p38 mitogen-
activated protein kinase (p38MAPK) and AKT via associ-
ation with scaffold proteins, JLP and Bnip2 for p38MAPK
[13, 14] and APPL1 for AKT [15]. The level of Cdo pro-
tein, presumably at the cell membrane, appears to be crit-
ical for initiation of promyogenic signaling pathways;
however, it is still unclear how the activity of the Cdo pro-
tein at the cell membrane is regulated.
Membrane fusion is an obligatory event in intracellular
membrane trafficking and physically merges two lipid bi-
layers of separate compartments allowing content mixing
[16]. Soluble N-ethylmaleimide-sensitive factor (NSF) at-
tachment protein receptor proteins (SNAREs) play a key
role in intracellular membrane fusion events and have been
divided into vesicle-membrane SNAREs (v-SNAREs) and
target-membrane SNAREs (t-SNAREs) based on their sub-
cellular localization [17]. Syntaxin 4 (Stx4) is a member of
t-SNAREs and expressed highly in various tissues, includ-
ing the skeletal muscle, and plays a critical role in glucose
uptake in response to insulin by delivery of glucose trans-
porter 4 (GLUT4) to the cell membrane in skeletal muscle
and adipose tissue [18, 19]. In addition, Stx4 has been
shown to regulate glucose-stimulated insulin secretion in
beta cells [20, 21]. The physiological importance of Stx4 inthe glucose uptake of skeletal muscle and whole body me-
tabolism has been shown by studies with knockout and
transgenic mice [19, 22]. Stx4 heterozygous mice display
an insulin resistance with reduction of glucose uptake spe-
cifically in the skeletal muscle, without alterations in adi-
pose tissue and liver [22]. Conversely, Stx4 transgenic mice
exhibit enhanced glucose uptake and insulin-induced
GLUT4 translocation to the cell membrane of the skeletal
muscle [19]. The complete ablation of the Stx4 gene in
mice causes early embryonic lethality before embryonic
day 7.5 [23]. Thus, whether Stx4 plays any role in myogen-
esis is still unclear. The facts that GLUT4 expression and
activity increase during myoblast differentiation [24] and
the fusion of myoblasts into multinucleated myotubes is a
critical step for efficient differentiation prompt us to exam-
ine the role of Stx4 in myoblast differentiation, especially
in regulation of a promyogenic surface receptor Cdo.
We report here that Stx4 expression is upregulated
upon induction of myoblast differentiation. Overexpres-
sion of Stx4 in C2C12 myoblasts increases myogenic dif-
ferentiation via regulation of p38MAPK activity, whereas
Stx4 depletion in C2C12 cells by small hairpin RNA
(shRNA) decreases myogenesis. Stx4 and Cdo interact
physically in differentiating myoblasts, and this inter-
action is mediated by the t-SNARE domain of Stx4,
which is critical for the promyogenic function of Stx4.
Stx4 depletion leads to declined levels of the cell surface
resident Cdo without changes in the level of N-
Cadherin, another Cdo-interacting protein. Interestingly,
Cdo depletion affected the membrane translocation of
GLUT4 and interaction of Stx4 with GLUT4, without al-
tered total protein levels. Taken together, Stx4 promotes
myogenic differentiation by binding to a promyogenic
receptor Cdo and regulating its cell surface translocation
thereby activating downstream p38MAPK pathway.
Methods
Cell culture and expression vectors
Myoblast C2C12 cells, primary myoblasts, embryonic
fibroblast 10T1/2 cells, and embryonic kidney 293T cells
were cultured as described previously [1]. To induce dif-
ferentiation of C2C12 myoblasts, cells at near confluence
were changed from Dulbecco modified Eagle’s medium
(DMEM) containing 15 % fetal bovine serum (FBS;
growth medium, GM) to DMEM containing 2 % horse
serum (HS; differentiation medium, DM), and myotube
formation was observed at 2 or 3 days of differentiation.
The efficiency of myotube formation was quantified by a
transient differentiation assay as previously described
[1]. To generate C2C12 cells that stably overexpress
Cdo, Stx4, mutant forms of Stx4, or shRNAs against
Stx4 or Cdo, cells were transfected with the indicated
expression vectors and Lipofectamine 2000 (Invitrogen,
Carlsbad, CA), and cultures were selected in puromycin-
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from Sigma-Aldrich (St. Louis, MO) were screened for
their effectiveness by transfection into 293T cells. From
among them, the following sequences were chosen based





For the Stx4 deletion mutation study, the mouse Stx4
gene was amplified by Reverse Transcription Polymerase
Chain Reaction (RT-PCR) of mRNAs purified from
human embryonic kidney fibroblast cells. Full-length Stx4
(aa 1-299) and deletion forms of Stx4 (Stx4Δ1-153,
Stx4Δ154-194, and Stx4Δ195-262) were inserted into
mammalian expression vector pcDNA-myc and
puroBABE-GFP-S, respectively. Hindlimb and satellite
cells isolated from Cdo+/+ and Cdo−/− mice were cultured
as described previously [25]. Cells were grown in F10
medium containing 20 % FBS and basic fibroblast growth
factor (bFGF; 100 ng/ml).
Western blot analysis and immunoprecipitation
Western blot analysis was performed as previously de-
scribed [26]. Briefly, cells were lysed in cell extraction
buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM
EDTA, 1 % Triton X-100) containing complete protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, IN),
and Sodium Dodecyl Sulfate - Polyacrylamide Gel
Electrophoresis (SDS-PAGE) was performed. The primary
antibodies used were anti-Stx4 (sc-101301), anti-MyoD
(sc-32758), anti-Myogenin (sc-12732), anti-myc (sc-40),
anti-GLUT4 (sc-53566, Santa Cruz Biotechnology,
Santa Cruz, CA), anti-troponin T (SAB2102501), anti-
pan-Cadherin (c3678, Sigma-Aldrich, St Louis, MO),
anti-p-p38 (9211), anti-p38 (9212), anti-phospho-AKT
(p-AKT; 9271), anti-AKT (9272, Cell Signaling Technology,
Beverly, MA), anti-GFP (A11120, Invitrogen), anti-Cdo
(AF2429, R&D Systems, Minneapolis, MN), and anti-
myosin heavy chain (MHC) (MF20: Developmental
Studies Hybridoma Bank, Iowa, IA). For immunopre-
cipitation assay, 293T cells were transfected with a
combination of Cdo and either myc-tagged Stx4 or
S-GFP-tagged Stx4. Thirty-six hours after transfection,
whole cell extracts were incubated with anti-myc and
protein G agarose beads (Roche Diagnostics) over-
night at 4 °C. The beads were washed three times with
extraction buffer and resuspended in extraction buf-
fer, and samples were analyzed by western blotting.
For pulldown experiments, 293T cells were trans-
fected with Cdo and deletion mutant of Stx4-S. Cell
extracts were incubated with anti-S beads (Novagen,
Madison, WI), and the precipitates were assessed by
immunoblotting.Biotin labeling of cell surface protein
Cell surface biotinylation was performed essentially as
described previously [27]. Briefly, C2C12 cells were
induced to differentiate for indicated time points by
switching to DM and incubating in phosphate-
buffered saline (PBS) containing Sulfo-NHS-LC-Biotin
(Thermo Fisher Scientific, Rockford, IL) with the final
concentration of 1 mg/ml for 30 min on ice. After
quenching the biotinylation, cells were lysed in extraction
buffer containing protease inhibitor. Biotinylated proteins
were recovered on streptavidin-agarose beads (Thermo
Fisher Scientific), followed by SDS-PAGE.
Immunocytochemistry and confocal microscopy
Immunostaining for MHC expression was performed as
described previously [1]. Briefly, C2C12 cells were trans-
fected with Cdo plus GFP vector or Stx4 and GFP vector,
fixed with 4 % paraformaldehyde for 20 min, permeabilized
with 1 % Triton X-100 in PBS for 10 min, blocked, and
stained with anti-MHC, followed by an FITC-conjugated
and Alexa Fluor 568-conjugated secondary antibody (Invi-
trogen). Images were captured and processed with a Nikon
ECLIPSE TE-2000U microscope and NIS-Elements F soft-
ware (Nikon). Quantitative differentiation assay was per-
formed for at least three independent experiments.
For reactivation of p38 in Cdo-depleted cells by Stx4
overexpression experiment, C2C12 cells in 12-well plates
were cotransfected with 100 ng of a GFP expression vector
and 900 ng of the indicated DNA construct for 2 days and
then fixed with 4 % paraformaldehyde for 20 min. Cultures
were then permeabilized with 1 % Triton X-100 in PBS,
blocked, and incubated with anti-p-p38 followed by in-
cubation with an Alexa Fluor 568-conjugated secondary
antibody. Nuclei were counterstained with 4',6-diamidino-
2-phenylindole (DAPI). An image was obtained on a Zeiss
LSM-510 Meta Confocal Microscope. Quantification of the
fluorescent signal for p-p38 was performed with Image
Gauge software (Fujifilm).
Luciferase assay
10T1/2 cells were seeded in 12-well plates at a density of
4 × 104 cells per well. Twenty-four hours after seeding, cells
were transfected using Lipofectamine 2000 with 100 ng of
the reporter plasmid of MyoD-luc and cotransfected with
50 ng MyoD. Twelve hours later, transfection cells were
transferred into GM, harvested, and firefly luciferase activ-
ity was determined using a Luminometer with Luciferase
Reporter Assay System (Promega, Fitchburg, WI). Experi-
ments were performed in triplicates and repeated at least
three times independently.
RNA extraction, RT-PCR, and quantitative RT-PCR
Total RNA was extracted using Easy-Blue reagent (iN-
tRON Biotechnology, Seongnam, Korea) according to
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reverse-transcribed from 2 μg of total RNA using oligo-
dT primer and SuperScript II reverse transcriptase (Invi-
trogen). The PCR mixture contained the template DNA,
primer, dNTPs, and DNA polymerase (Invitrogen). PCR re-
actions were performed in a Genepro-PCR model. Expres-
sion levels of glyceraldehyde 3-phosphate dehydrogenase
(Gapdh) were used to normalize the expression levels of
each sample. Primer sequences used for PCR were as




pdh, 5′-ATGGGGAAGGTGAAGGTCG-3′ and 5′-TTAC
TCCTTGGAGGCCATGT-3′. Each PCR reaction was ana-
lyzed on 1.2 % agarose gel containing ethidium bromide.
Real-time PCR was performed using SYBR Green PCR
master mix in an ABI cycler and quantified with ABI 7000
software (Applied Biosystems, Foster City, CA). Briefly,
1 μg of total RNAs was reverse-transcribed for 5 min at
72 °C and incubated for 5 min on ice followed by incuba-
tion for 60 min at 42 °C and 5 min at 95 °C. One hundred
nanograms cDNA and 0.2 μl universal reverse (Invitrogen)
and specific forward primer were used for the 20 μl PCR
reaction. All PCR reactions were analyzed as triplicates.
Measurement of glucose uptake
Stable C2C12 cells transfected with control, Cdo, or
shCdo expression vector were incubated in the serum-,
glucose-free DMEM for 2 h at 37 °C. After the incuba-
tion, cells were treated with 10 μg/ml insulin in the
serum-, glucose-free DMEM for 1 h, and 100 μM 2-[N-
(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-
glucose (2-NBDG) was added, a fluorescent glucose ana-
log (Invitrogen) for 1 h. Reactions were terminated by
washing with a cold DPBS buffer, followed by measure-
ment of the fluorescence intensity at an excitation of
485 nm and an emission of 535 nm using a Lumin-
ometer (Promega).
Statistics
The experiments were performed independently at least
three times. The participants’ t-test was used to access
the significance of the difference between two mean
values. *p < 0.01 and **p < 0.05 were considered to be
statistically significant.
Results
Stx4 is expressed in skeletal muscles and enhanced
during myoblast differentiation
In the previous study, we performed a yeast two-hybrid
screening to identify interacting proteins for Cdo, and
JLP and Bnip2 are two such proteins implicated in Cdo-
mediated myogenesis [13, 14]. In the same screen,Syntaxin (Stx) 1 was identified as an interacting protein
for Cdo. Stx1 and Stx4 share high homology and have
similar domain structures consisting of Stx, t-SNARE, and
transmembrane domain (TD) [28]. While Stx1 is
expressed predominantly in neural cell types, Stx4 is the
major form in skeletal muscles [29, 30]. Therefore, we ex-
amined whether Stx4 plays a role in myogenesis, especially
in association with Cdo. First, we have assessed the ex-
pression pattern of Stx4 and Cdo in mouse hindlimb mus-
cles from various developmental stages. The expression of
Stx4 was detected throughout the examined stages; how-
ever, the level of Cdo, MyoD, and Myogenin decreased
after the postnatal day 7 which may reflect the fast muscle
growth during early postnatal life (Fig. 1a). Next, we have
examined the expression pattern of Stx4 protein during
myoblast differentiation. C2C12 cells were grown to near-
confluency (D0) and induced to differentiate by switching
to the differentiation medium for a total of 3 days (D3),
followed by immunoblotting. As shown in Fig. 1b, the
level of Stx4 is enhanced progressively during myoblast
differentiation, while the Cdo protein is expressed
throughout the differentiation time course, and the ex-
pression of Myogenin and myosin heavy chain (MHC)
was dramatically enhanced at D2 or D3, respectively.
These data suggest that Stx4 might be important for myo-
blast differentiation. Since Cdo and Stx4 were coexpressed
in developing skeletal muscles, we examined the relation-
ship between Cdo and Stx4 by using primary myoblasts
isolated from Cdo+/+ or Cdo−/− mice. Previously, we have
shown that Cdo-deficient primary myoblasts display de-
fects in myoblast differentiation and p38MAPK activation
[26]. Cdo+/+ or Cdo−/− myoblasts at high cell density (D0)
were induced to differentiate by removal of basic fibro-
blast growth factor (bFGF) for 2 days. The expression of
Stx4 in Cdo−/− myoblasts was substantially increased at
D2 compared to that of Cdo+/+ myoblasts, whereas there
was only slight or no difference at D0 and D1 (Fig. 1c). In
addition, the qRT-PCR analysis showed that Stx4 tran-
script levels were increased at D1 in Cdo-deficient myo-
blasts, but no difference in cells at D0 or D2 (Fig. 1d).
These data suggest that the Stx4 expression level alone
may not be sufficient to induce myoblast differentiation
when Cdo is deficient.
Overexpression of Stx4 enhances myogenic differentiation
To investigate the function of Stx4 in myogenesis, C2C12
cells were stably transfected with control or Stx4 expression
vectors and induced to differentiate. Overexpression of
Stx4 in C2C12 cells generally resulted in a twofold increase
of Stx4 protein (Fig. 2a) and the expression of muscle-
specific genes including MHC; Myogenin and Troponin T
were significantly enhanced in Stx4-overexpressing C2C12
cells, compared to that of control cells, while MyoD levels
were not altered (Fig. 2b). Next, we examined the effect of
Fig. 1 Stx4 is expressed in skeletal muscles and induced in myoblast differentiation. a RT-PCR analysis of hindlimb muscles from E15.5 embryos
and P1, P5, P7, P14, and P30 mice for the expression of Stx4, Cdo, MyoD, Myogenin, and 18S rRNA serves as a loading control. b Immunoblot
analysis of C2C12 cells from various differentiation days (D) for the expression of Stx4, Cdo, Myogenin, MHC, and pan-Cadherin serves as a loading
control. c Immunoblot analysis for Stx4 protein expression in Cdo+/+ and Cdo−/− primary myoblasts during differentiation, and pan-Cadherin
serves as a loading control. d qRT-PCR analysis for Stx4 mRNA expression in Cdo+/+ and Cdo−/− primary myoblasts during differentiation
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(pcDNA) and Stx4-overexpressing C2C12 cells were in-
duced to differentiate for 2 days, fixed, and immunostained
with anti-MHC antibody followed by DAPI staining. Stx4-
overexpressing C2C12 cells formed larger myotubes than
the control (pcDNA) cells (Fig. 2c, d). MHC-positive cells
were scored as mononucleate, containing two to five nuclei,
containing six to nine nuclei, or containing ten or more nu-
clei. Stx4-overexpressing cells formed more larger myo-
tubes containing six to nine nuclei (18 %) and ten or more
nuclei (15 %), compared to control cells with 10 and 3 %,
respectively. In contrast, the percentile of mononucleate
cells decreased to 38 %, compared to 53 % of control cells
(Fig. 2d). These data suggest that Stx4 promotes myoblast
differentiation.
The depletion of Stx4 decreases myogenic differentiation
To examine whether Stx4 depletion inhibits muscle-
specific gene expression and myotube formation, C2C12
cells were stably transfected with control pSuper or Stx4
shRNA (shStx4) expression vectors, induced to differen-
tiate for 3 days and analyzed for their differentiation
ability by Western blot analysis and immunostaining
with anti-MHC antibody. We have tested five different
Stx4 shRNA expression vectors, and among them, two
shRNA constructs reproducibly resulted in a significant
knockdown of Stx4. Among these, we used mostly
shStx4#1 for this study (Additional file 1: Figure S1).Stx4 protein levels decreased to 34 % in C2C12/shStx4
cells, relative to that of C2C12/pSuper cells (Fig. 2e).
Stx4-depleted cells exhibited a dramatic reduction in the
expression of MHC, MyoD, Myogenin, and Troponin T,
compared to C2C12/pSuper cells (Fig. 2f ). Furthermore,
C2C12/shStx4 cells formed smaller myotubes with fewer
nuclei, relative to C2C12/pSuper cells (Fig. 2g). The
quantification of MHC-positive cells showed that Stx de-
pletion resulted in the formation of more mononucle-
ated myocytes (~57 to ~67 %) and less myotubes with
more than six nuclei (~17 to ~9 %), relative to C2C12/
pSuper cells (Fig. 2h). These results indicate that Stx4 is
required for efficient myoblast differentiation.
Stx4 and Cdo interact physically in differentiating
myoblasts, and this interaction is mediated by the t-SNARE
domain of Stx4
Next, we examined whether Stx4 and Cdo physically in-
teracts in mammalian cells. To do so, 293T cells were
transiently transfected with myc-tagged Stx4 and Cdo
and then lysates were immunoprecipitated with the
myc-tag antibody followed by immunoblotting with Cdo
and myc antibodies. Consistent with the result obtained
from a previous yeast two-hybrid screening [13], Stx4
and Cdo interacted in 293T cells when coexpressed
(Fig. 3a). To assess whether Stx4 and Cdo interact en-
dogenously in myoblasts, cell lysates of differentiating
C2C12 myoblasts from a total of 3 days of differentiation
Fig. 2 (See legend on next page.)
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Fig. 2 Overexpression or knockdown of Stx4 promotes or blocks myoblast differentiation, respectively. a Lysates of control or Stx4-overexpressing
C2C12 cells were immunoblotted with antibodies against Stx4 and pan-Cadherin as a loading control. The relative signal intensity of Stx4 to
pan-Cadherin was quantified and added under the blot. b Lysates of control or Stx4 expression vector transfected C2C12 cells from the differentiation
day 1 (D1) and D2 were immunoblotted with antibodies to MHC, MyoD, Myogenin, Troponin T, and pan-Cadherin as a loading control. c Control or
Stx4 expression vector transfected C2C12 cells were induced to differentiate for 3 days and immunostained with MHC antibody followed by DAPI
staining to visualize nuclei. Size bar = 100 μm. d The quantification of myotube formation shown in panel c. Values represent means of triplicate
determinations ± 1 SD. The experiment was repeated three times with similar results. Significant difference from control, *p < 0.01. e Control or shStx4
expression vector transfected C2C12 cells were analyzed by immunoblotting with antibodies to Stx4 and pan-Cadherin as a loading control. The
relative knockdown levels of Stx4 to pan-Cadherin are quantified and added under the blot. f Control or shStx4 expression vector transfected C2C12
cells were induced to differentiate for 2 or 3 days and then lysates were subjected to immunoblotting with antibodies to MHC, MyoD, Myogenin,
Troponin T, and pan-Cadherin as a loading control. g Control pSuper or shStx4 expression vector transfected C2C12 cells were induced to differentiate
for 3 days and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar = 100 μm. h The quantification of
myotube formation shown in panel g. Values represent means of triplicate determinations ± 1 SD. The experiment was repeated three times with
similar results. Significant difference from control, *p < 0.01, **p < 0.005
Fig. 3 Stx4 and Cdo interact physically in differentiating myoblasts, and the t-SNARE domain of Stx4 mediates the interaction with Cdo. a Lysates
of 293T cells transfected with Stx4-myc, Cdo, or control vector were subjected to immunoprecipitation with myc and immunoblotting with Cdo
or myc antibodies. b Lysates of C2C12 cells from various differentiation time courses were immunoprecipitated with control IgG or anti-Cdo
antibody and immunoblotted with antibodies to Stx4, Cdo, and pan-Cadherin as a loading control. c The schematic representation of the domain
structure of Cdo. Cdo consists of five immunoglobulin, three fibronectin type III, a single transmembrane domain, and a 270-amino-acid-long
intracellular region. d 293T cells were transiently cotransfected with control or Stx4-myc along with either the full length or three deletion mutants of
the Cdo’s cytoplasmic region. Forty-eight hours later, cell lysates were subjected to immunoprecipitation with myc antibody followed by
immunoblotting with Cdo antibody. Total lysates served as the expression controls. e The schematic representation depicts the domain structure of
Stx4 and the deletion of the specific domain; Δ33-153 (the Syntaxin domain deletion), Δ195-262 (the t-SNARE region deletion), and Δ154-194
(the linker region deletion). f 293T cells were transiently cotransfected with control or Cdo along with the full length or deletion mutants of Stx4, and
the lysates were pulled down with S-agarose beads followed by immunoblotting with Cdo or GFP antibodies
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an anti-Cdo antibody and analyzed by Western blotting.
Stx4 was precipitated with Cdo throughout differentiation
time course, and the coprecipitation was highest at D2
(Fig. 3b) when myoblasts were differentiating (Fig. 1b).
These results suggest that Stx4 and Cdo can physically
interact in myoblasts during differentiation.
Cdo consists of an extracellular region that contains five
immunoglobulin (Ig)-like repeats followed by three fibro-
nectin type III (FNIII)-like repeats, a transmembrane seg-
ment, and a long cytoplasmic tail [31]. A schematic
representation of the Cdo protein structure is shown in
Fig. 3c. To determine the cytoplasmic region of Cdo
which is responsible for interaction with Stx4, we have
transiently transfected three Cdo mutants that harbor in-
dicated deletions in the cytoplasmic tail and analyzed the
ability of these mutants to coprecipitate with Stx4. All
three Cdo mutants showed a reduction in Stx4 binding,
relative to the full length. However, CdoΔ986-1048 and
CdoΔ1035-1160 failed to coprecipitate Stx4 (Fig. 3d), sug-
gesting the cytoplasmic region of Cdo is required for Stx4
interaction.
To identify the domain of Stx4 responsible for Cdo
interaction, we have generated GFP-S-tagged Stx4 dele-
tion mutants based on its domain structure (Fig. 3e).
The full length or these deletion mutants of Stx4 were
cotransfected into 293T cells with Cdo expression vector
followed by a pulldown analysis with S-agarose beads
and Western blot analysis. While Stx4Δ33-153 and
Stx4Δ154-194 proteins pulled down Cdo similarly to the
full-length Stx4, Stx4Δ195-262 failed to precipitate Cdo,
suggesting that the t-SNARE domain (aa 195–262) of
Stx4 is responsible for Cdo binding (Fig. 3f ).
The deletion mutants for either the Syntaxin or the t-SNARE
domain of Stx4 failed to enhance myoblast differentiation
The promyogenic function of Cdo involves the activation
of MyoD via p38MAPK pathway [1]. Therefore, we
assessed the effect of Stx4 or/and Cdo expression on
MyoD activation by using a MyoD-responsive reporter.
To do so, 10T1/2 fibroblasts were cotransfected with a
MyoD-luciferase construct and a MyoD expression vec-
tor along with expression vectors for Stx4 and/or Cdo.
Forty-eight hours later, lysates were subjected to a lucif-
erase assay. The expression of Stx4 or Cdo singly with
MyoD enhanced the luciferase activity approximately
2.5-fold and 2.7-fold, respectively, while coexpression of
Stx4 and Cdo enhanced the MyoD-reporter activity to
approximately 5.8-fold compared to control MyoD-
expressing cells (Fig. 4a). These data suggest that Stx4
and Cdo can activate MyoD cooperatively.
To assess the functional significance of the Stx4 inter-
action with Cdo in myoblast differentiation, C2C12 cells
stably transfected with the control, the full length, ordeletion mutants of Stx4 as indicated and induced to dif-
ferentiate for 2 days followed by Western blotting for
MHC expression. C2C12 cells expressing either the full-
length Stx4 or Stx4Δ154-194 displayed enhanced MHC
expression, compared to control-vector-expressing cells.
In contrast, the expression of Stx4Δ33-153 or Stx4Δ195-
262 resulted in starkly decreased MHC expression
(Fig. 4b). To assess the effect of Stx4 deletion mutants
on myotube formation, C2C12 cells were cotransfected
with the control pcDNA, the full length, or deletion mu-
tants of Stx4 and GFP to mark transfectants and induced
to differentiate for 3 days followed by immunostaining for
MHC expression. Consistent with the Western blot data,
the expression of Stx4Δ154-194 enhanced myotube
formation to a comparable level of the full-length Stx4, as
seen by fewer GFP-positive MHC-negative cells and larger
GFP-positive myotubes with more nuclei per myotube,
relative to control cells (Fig. 4c, d). However, roughly 60 %
of the control pcDNA, Stx4Δ33-153-, or Stx4Δ195-262-
expressing cells were negative for MHC expression, and a
large proportion of the GFP- and MHC-positive cells were
mononucleated in these cultures. These results suggest
that the Syntaxin and t-SNARE domains of Stx4 are re-
quired for the promyogenic function of Stx4.
Stx4 enhances p38MAPK phosphorylation, and Stx4
overexpression restores myoblast differentiation in
Cdo-depleted cells
Previously, we have reported that Cdo promotes myo-
blast differentiation via activation of a key promyogenic
kinase p38MAPK (p38) [13], and this is required for the
efficient myoblast differentiation [13, 32]. Therefore, we
examined the effect of Stx4 on p38 activation in C2C12
cells. Control or Stx4-overexpressing C2C12 cells were
induced to differentiate for 2 days, and the status of p38
activation was analyzed by Western blot analysis with
antibodies to an active phosphorylated form of p38 (p-
p38) or total p38. Overexpression of Stx4 led to a sub-
stantial increase in p-p38 levels relative to that of control
cells, while the level of total p38 was unchanged (Fig. 5a).
In addition, C2C12/pSuper or C2C12/shStx4 cells were
induced to differentiate for 3 days and analyzed for p38
activation. Stx4 knockdown in C2C12 cells caused a not-
able decrease in p-p38 levels relative to that of the con-
trol cells (Fig. 5b), suggesting that Stx4 is required for
p38 activation during myoblast differentiation. We next
asked whether the decreased p38 activation in Cdo-
depleted C2C12 cells can be rescued by Stx4 expression.
C2C12/pSuper and C2C12/shCdo cells were transiently
transfected with pcDNA or Stx4 expression vector, plus
GFP expression vector to label the transfectants. After
2 days of transfection, cells were immunostained with anti-
bodies to p-p38 and GFP followed by DAPI staining to
visualize nuclei. The representative pictures are shown in
Fig. 4 Stx4 and Cdo induce MyoD activities synergistically, and the Cdo-binding deficient Stx4 mutant failed to enhance myotube formation. a
10T1/2 cells were cotransfected with a MyoD-luciferase reporter and the expression vectors for MyoD and β-galactosidase as an internal control.
In addition, control, Stx4, and/or Cdo expression vectors were cotransfected as indicated. Forty-eight hours later, the reporter activities were
measured and normalized relative to the internal control. The experiment was performed as triplicates and repeated three times with similar
results. *p < 0.01. b Lysates of C2C12 cells stably transfected with indicated Stx4 vectors were immunoblotted with antibodies to MHC and
pan-Cadherin as a loading control. The relative signal intensities of MHC to pan-Cadherin were quantified and added under the blot. c C2C12 cells
were transiently cotransfected with control (pcDNA), Stx4, or Stx4 mutants along with a GFP expression vector to mark the transfectant. Then, cells
were induced to differentiate for 2 days, followed by immunostaining with an antibody to MHC and DAPI stain. Size bar = 100 μm. d Quantification of
myotube formation of cell lines shown in panel c. Values represent means of triplicate determinations ± 1 SD. The experiment was repeated three
times with similar results. Significant difference from control, *p < 0.01, **p < 0.005
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cells were positive for the nuclear p-p38 accumulation
(marked with a white arrow), whereas 63 % of Stx4-
transfected C2C12/pSuper cells were positive for p-p38.
On the other hand, only 17 % of control-transfected
C2C12/shCdo cells were weakly positive for p-p38, whereas
Stx4-expressing C2C12/shCdo cells displayed restored
p-p38 levels with 31 % which is similar to control-
transfected C2C12/pSuper cells (Fig. 5d). The quantification
of relative p-p38 signal intensities in GFP-positive cells re-
vealed the increased signal intensity in Stx4-overexpressing
control cells. Furthermore, the overexpression of Stx4 re-
stored p38 activation in C2C12/shCdo cells (Fig. 5e).
To further confirm these results, C2C12/pSuper and
C2C12/shCdo cells were transfected with control or
Stx4 expression vectors and induced to differentiate for2 days, followed by Western blot analysis. As expected,
C2C12/pSuper cells overexpressing Stx4 displayed ele-
vated p-p38 levels while control transfected Cdo-depleted
cells showed a reduction in p-p38 levels. In consistent
with the aforementioned data, Stx4 expression in C2C12/
shCdo cells restored p38 activation (Fig. 5f). Since Cdo
can activate AKT via interaction with APPL1 in promo-
tion of myoblast differentiation [15], we next examined
the effect of Stx4 on AKT activation in C2C12 cells. How-
ever, the active phosphorylated AKT levels were not al-
tered by depletion or overexpression of Stx4 (Additional
file 2: Figure S2). These data suggest that Stx4 overexpres-
sion can override the block of p38MAPK activation
caused by Cdo depletion in C2C12 myoblasts.
To further examine the role of Stx4 in Cdo-mediated
p38 activation, we have assessed the effect of Stx4
Fig. 5 Overexpression of Stx4 can override the block of myoblast differentiation in Cdo-depleted cells. a, b C2C12 cells were transfected with
control, Stx4, or shStx4 expression vectors, and the lysates were analyzed for the levels of phospho-p38MAPK (p-p38) relative to total p38MAPK
(p38). The relative levels of p-p38 are quantified and added under each well. c C2C12/pSuper and C2C12/Cdo shRNA cells were transiently
transfected with pcDNA or Stx4 expression vector, plus GFP expression vector to mark transfectants. Confluent cultures were then fixed and
stained with antibody to p-p38 (red). Cell nuclei were visualized by staining with DAPI (blue). The white arrows in p-p38 panels mark the
transfected cells. Size bar = 10 μm. d Quantification of cultures shown in c. GFP+ cells were scored as positive or negative for p-p38 staining. These
experiments were repeated three times with similar results. Significant difference from control, *p < 0.01. e Quantification of the relative signal
strength of p-p38 in GFP-positive cells. Values are determinants of 10 fields and experiments were repeated three times with similar results.
*p < 0.01. f C2C12/pSuper and C2C12/Cdo shRNA cells were transiently transfected with pcDNA or Stx4 expression vector, and the lysates were
analyzed for the levels of phospho-p38MAPK (p-p38) relative to total p38MAPK (p38). The relative levels of p-p38 are quantified and added under
each well. g C2C12 cells were transfected with pSuper or shStx4 expression vectors and were immunoprecipitated with control IgG or anti-Cdo
antibody and immunoblotted with antibodies to JLP, Bnip2, Cdo, Stx4, and pan-Cadherin as a loading control. h Similar sets of cells as shown in panel
c were induced to differentiate for 3 days and immunostained for MHC and GFP expressions. Size bar = 100 μm. i Quantification of myotube formation
from panel e. GFP+ myotubes were quantified for MHC expression and the number of nuclei present in myotubes. Values are determinants of more
than 10 fields and these experiments were repeated three times with similar results. Significant difference from control, *p < 0.01, **p< 0.005
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and JLP which has been shown to be critical for p38 acti-
vation and myogenic differentiation [13, 14]. C2C12 cells
were transfected with control or shStx4 expression vector
and induced to differentiate for 2 days. Cell lysates weresubjected to immunoprecipitation with control IgG or
anti-Cdo antibody followed by immunoblotting. The inter-
action of Cdo with JLP, Bnip2, and Stx4 was abrogated in
Stx4-depleted cells compared to control cells (Fig. 5g).
Interestingly, Cdo levels in total lysates were slightly
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JLP and Bnip2 were not altered. These data suggest that
Stx4 is required for Cdo/Bnip2/JLP complex formation.
This led us to investigate whether overexpression of
Stx4 can restore the differentiation ability of Cdo-
depleted myoblasts. C2C12/pSuper and C2C12/shCdo
cells were transiently transfected with pcDNA or Stx4
plus GFP expression vectors to label the transfectants
and induced to differentiate for 3 days, followed by im-
munostaining with a MHC antibody and DAPI staining.
Consistently, Stx4 overexpression in C2C12/pSuper cells
enhanced myotube formation as seen by the increased
proportion of larger myotubes containing more than six
nuclei compared with the control transfected cells
(Fig. 5h, i). Similarly to the previous reports [26],
C2C12/shCdo cells transfected with the control pcDNA
exhibited impaired myotube formation. Overexpression
of Stx4 in these cells restored myotube formation to
similar levels of control cells (Fig. 5h, i). These results
demonstrate that overexpression of Stx4 can restore the
differentiation ability of Cdo-depleted C2C12 myoblasts.Depletion of Stx4 causes a reduction in Cdo protein levels
at the cell surface
Next, we examined whether Stx4 regulated Cdo trans-
location to cell surface. To do so, we have assessed
whether Stx4 depletion altered the level of Cdo at the
cell surface by surface biotinylation. Stx4 knockdowned
C2C12 cells displayed decreased Cdo protein levels at
the cell surface as well as total Cdo proteins in lysates
(Fig. 6a). Furthermore, this effect on Cdo levels appears
to be specific since N-Cadherin levels did not alter in
these cells. To further examine, C2C12/pSuper or
C2C12/shStx4 cells were transfected with a Cdo-GFP
vector and subjected to immunostaining with a Cadherin
antibody to label the membrane and confocal micros-
copy. Cdo-GFP proteins were found at the cell mem-
brane and intracellular compartments in both cell types.
However, the signals of Cdo-GFP and Cadherin were
partially superimposed at the membrane in control cells,
whereas Cdo-GFP and Cadherin signals did not largely
overlap at the membrane in Stx4-depleted cells (Fig. 6a).
Next, we assessed whether the amount of Cdo at the cell
surface is rescued by Stx4 in Cdo-depleted C2C12 cells.
C2C12/shCdo cells were transfected with the Stx4 ex-
pression vector, and 24 h later, cells were analyzed by
surface biotinylation. At this condition, Cdo was de-
creased in both pcDNA and Stx4-transfected C2C12/
shCdo cells, compared to the control C2C12/pSuper
cells (Fig. 6c). Consistently, the biotinylated Cdo levels
were decreased in control C2C12/shCdo cells while Stx4
overexpression restored the biotinylated Cdo levels in
C2C12/shCdo cells to the control C2C12/pSuper cells.These data suggest that Stx4 enhances Cdo translocation
to the cell surface thereby stimulating Cdo-mediated
p38 activation and myoblast differentiation.
Next, we have assessed whether Cdo is involved in
GLUT4 trafficking to the cell surface mediated by Stx4.
To do so, C2C12/pSuper or C2C12/shCdo cells were in-
duced to differentiate for 1 day and analyzed for the sur-
face biotinylation of GLUT4. The biotinylated GLUT4
levels were decreased in Cdo-depleted cells, while total
GLUT4 levels did not alter (Fig. 6d). Interestingly,
GLUT4 interaction with Stx4 was decreased in Cdo-
depleted C2C12 cells, without affecting the total expres-
sion levels of these proteins (Fig. 6e). To assess the effect
of Cdo on glucose uptake in C2C12 myoblasts, cells
were stably transfected with control, Cdo, or shCdo ex-
pression vectors and treated with insulin and a fluores-
cent glucose analog 2-NBDG. Overexpression of Cdo in
C2C12 cells generally resulted in a twofold increase of
2-NBDG uptake, while Cdo depletion reduced the level
of 2-NBDG uptake to about 71 % in C2C12/shCdo cells,
relative to that of control cells (Fig. 6f ). Taken together,
these data suggest that Stx4 regulates Cdo protein levels
at the cell surface thereby enhancing the promyogenic
signal triggered by Cdo, such as p38MAPK. In turn, this
signaling appears to be critical for GLUT4 translocation
to the cell membrane mediated by Stx4.
Discussion
In the skeletal muscle, the role of Stx4 in glucose uptake
through stimulation of GLUT4 translocation to the cell
membrane in response to insulin has been well docu-
mented [19]. The fact that GLUT4 expression and trans-
location, likely via Stx4, exclusively induced in
differentiating muscle cells [33] suggests a potential link
between promyogenic signaling pathways and Stx4/
GLUT4 activation to promote myoblast differentiation.
Our current study suggests that Stx4 plays a critical role
for myoblast differentiation. Overexpression or knockdown
of Stx4 enhances or inhibits myogenic differentiation via
regulation of promyogenic signaling molecules Cdo and
p38. Stx4 and Cdo interact physically in differentiating
myoblasts, and this interaction is mediated by the t-
SNARE domain of Stx4, which is critical for the promyo-
genic function of Stx4. Through this interaction, Stx4 ap-
pears to regulate translocation of Cdo to the plasma
membrane. It is noteworthy that Stx4 depletion results in a
specific decrease in Cdo protein at the cell surface without
altering N-Cadherin levels which can also interact with
Cdo and promote myoblast differentiation. Vesicle trans-
port is regulated via multiple steps including formation of
vesicles or tubular intermediates, movement of vesicles to-
wards the target compartments, tethering/docking with the
acceptor membrane, and fusion of the lipid bilayers [34].
For the membrane trafficking, the specific interaction of
Fig. 6 The cell-surface-resident Cdo was specifically decreased in Stx4-depleted C2C12 cells. a C2C12 cells were transfected with pSuper or shStx4
expression vectors, and cells at the indicated differentiation time points were subjected to the surface biotin labeling, followed by the pulldown
with streptavidin and immunoblotting. Total cell lysates were also analyzed as control. b C2C12/pSuper or C2C12/shStx4 cells were transfected
with Cdo-GFP expression vectors and subjected to immunostaining with N-Cadherin antibody, followed by confocal microscopy. The boxed area
is shown as an enlarged view. The white arrows mark the area where the localization of Cdo-GFP under the N-Cadherin-resident cell surface is
located. Size bar = 10 μm. c C2C12/pSuper or C2C12/shCdo cells were transfected with pcDNA or Stx4 expression vectors and subjected to the
surface biotin labeling, followed by the pulldown with streptavidin and immunoblotting. Total cell lysates were analyzed as control. d Control or
shCdo-transfected C2C12 cells at D1 were subjected to surface biotinylation followed by streptavidin-bead pulldown and immunoblotting with
indicated antibodies. e Control or shCdo expression vector transfected C2C12 cells were immunoprecipitated with antibody to GLUT4 and
immunoblotted with antibodies to GLUT4, Stx4, and Cdo. f Stable C2C12 cells transfected with control, Cdo, or shCdo expression vector were
incubated with or without 10 μg/ml insulin for 1 h, followed by 2-NBDG incubation for a further 1 h. Glucose uptake was measured by the
relative fluorescence intensity. The experiment was repeated for three independent assays with similar results. Significant difference from
insulin-incubated cells, *p < 0.05, **p < 0.01
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of the Rab family are important in the stage of vesicle teth-
ering, and SNAREs might mediate membrane fusion [34].
The mechanism how some SNAREs function in several
trafficking steps and substitute for other SNAREs [35] is
still unclear. In this study, we show that Cdo is a new
SNARE-binding protein and directly interacts with Stx4
that regulates its cell surface localization. Considering the
relatively short half-life of Cdo protein (~2 h) [36], theincreased levels of Stx4 in differentiating myoblasts might
ensure fast and continuous membrane trafficking of Cdo
to promote myogenic differentiation. The interaction of
Stx4 and Cdo can be detected already at D0 before the dif-
ferentiation initiation. Considering cell adhesion signaling
is an important regulator for myogenic differentiation and
both Cdo and Stx4 are induced by the high cell density at
D0, Cdo and Stx4 might be required for the initial stage of
myogenic differentiation. In consistent with this notion,
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ation while depletion of these genes delays it. Thus, it is
conceivable that Cdo-mediated signaling might be regu-
lated via two sequential steps. At D0 with cell adhesion
signaling, Cdo is induced and translocated to the cell sur-
face. Subsequently, the removal of serum might relieve
Cdo-mediated signaling from inhibition by growth factor
signaling resulting in activation of Cdo-mediated signaling
and induction of myoblast differentiation. Currently, it is
unclear whether growth factor signaling directly affects
Cdo-mediated signaling.
In muscle and fat cells, insulin stimulates the delivery
of GLUT4 from an intracellular location to the cell sur-
face, where it facilitates glucose uptake thereby control-
ling the plasma glucose levels [37]. Insulin-stimulated
GLUT4 translocation seems to be regulated mainly via
activation of phosphatidylinositol 3-kinase (PI3-kinase)
and the AKT pathway [38]. Muscle contraction and hyp-
oxia associated with exercise have been shown to regu-
late glucose uptake mainly via AMP-activated protein
kinase and the CAMKII pathway [39]. In addition, p38
has been shown to regulate GLUT4 activity and glucose
uptake during L6 myoblast differentiation, and inhibition
of p38 reduces GLUT4 translocation and glucose uptake
[33]. Previously, we have shown that the Cdo’s promyo-
genic function is mainly mediated by p38 which in turn
activates post-translationally myogenic bHLH transcrip-
tion factors, such as MyoD [26]. Stx4 overexpression and
knockdown increased and reduced p38 activities, respect-
ively (Fig. 5a, b). However, it appears that Stx4-mediated
p38 activation requires Cdo, since Cdo-deficient myo-
blasts exhibit a decrease in the level of p-p38 and the
membrane-resident GLUT4 proteins (Fig. 5c, d and
Fig. 6d). Other components of Cdo-multiprotein com-
plexes, including Boc, neogenin, and Cadherins, might be
also regulated though membrane trafficking by SNARE
proteins, since their expression is upregulated during
myogenic differentiation [8], though Stx4 appears not to
be regulating translocation of Cadherins. Interestingly,
Stx4 overexpression in C2C12/shCdo cells restores the
level of Cdo at the cell surface to the similar levels of the
control C2C12/pSuper cells. Thus, it is likely that Stx4
might restore differentiation of Cdo-knockdown C2C12
cells via enhancing translocation of the residual Cdo. In
addition, Stx4 might also regulate the translocation of
other components of the Cdo-multiprotein complex such
as Boc or neogenin which can stimulate Cdo-mediated
myogenic differentiation. However, we cannot exclude the
possibility that Stx4 may stimulate translocation of other
cell membrane protein which can also activate p38 and in-
duce myogenic differentiation. Further study will be re-
quired for elucidation of detailed mechanisms.
Cdo knockdown resulted in decreased interaction be-
tween Stx4 and GLUT4, and overexpression or knockdownof Cdo increases or decreases glucose uptake, respectively.
These data suggest that Cdo-mediated p38MAPK activa-
tion may trigger Stx4 and Glut4 interaction which may trig-
ger GLUT4 translocation to plasma membrane and glucose
uptake in myoblast differentiation (Fig. 6e, f). Thus, it is
conceivable that Stx4 induces translocation of Cdo first
which in turn activates p38MAPK leading to the activation
of Glut4 and glucose uptake during myoblast differentiation
[33]. The expression of deletion mutants for the Syntaxin
or t-SNARE domain responsible for Cdo binding had a
dominant negative effect on MHC expression further sup-
porting for the importance of interaction between Stx4 and
Cdo and Stx4 function for its promyogenic function
(Fig. 4b). It appears that the Stx4-mediated Cdo activation
induces specifically p38MAPK activation since overexpres-
sion or knockdown of Stx4 did not affect the activity of
another promyogenic kinase AKT which can be also
upregulated by Cdo/APPL1 complexes [15]. This result
suggests that the surface translocation of Cdo may not
be required for AKT activation and further studies are
needed to understand the detailed mechanism.
Microtubule dynamics have been shown to play an es-
sential role in trafficking of vesicles and protein trans-
ports mediated by Stxs [40]. We have previously
reported that Cdo interacts with Stim1 to regulate
calcium-mediated signaling which is critical for induc-
tion of myoblast differentiation [41]. Interestingly, Stim1
can also interact with the microtubule plus end tracking
protein EB1 that stabilizes the microtubule structure
thereby regulating the interaction between endoplasmic
reticulum and cell membrane [42]. Thus, it is plausible
that Cdo localization may be regulated by a transport net-
work involving Stim1/EB1/microtubule and Stx4 at the cell
membrane. Further studies will determine whether compo-
nents of vesicle trafficking and microtubule organization
are involved in regulation of Cdo proteins and myogenesis.
In the original yeast two-hybrid screening, Stx1B was iden-
tified as an interacting protein for Cdo [13]. Stx1 is a cen-
tral component of the neuronal SNARE complex and
believed to play an essential role in neurotransmitter exo-
cytosis [17]. In addition, Stx1B has been implicated in
neuronal survival [43, 44]. In our previous studies, Cdo
has been shown to regulate neuronal differentiation via
p38MAPK activation [45]; a similar mechanism may be ap-
plied to regulation of neuronal differentiation. The defined
underlying mechanism by which Cdo and Stx1B may regu-
late neuronal differentiation will be addressed in the future.
Conclusions
In conclusion, we have examined the roles of Stx4 in myo-
blast differentiation. Overexpression or knockdown of Stx4
enhances or inhibits myogenic differentiation, respectively,
via regulation of promyogenic signaling molecules Cdo
and p38MAPK. Stx4 and Cdo interact physically in
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ated by the t-SNARE domain of Stx4, which is critical
for the promyogenic function of Stx4. Stx4 depletion
decreases specifically the cell surface resident Cdo, and
the level of cell surface resident GLUT4 and interaction
between GLUT4 and Stx4 are declined in Cdo-depleted
cells. Therefore, interaction with Cdo and regulation of
its cell surface localization by Stx4 are necessary for
myogenic differentiation. In turn, this signaling appears
to be critical for GLUT4 translocation to the cell mem-
brane by Stx4 and glucose uptake.
Additional files
Additional file 1: Figure S1. Knockdown of Stx4. Control or shStx4
expression vector transfected C2C12 cells were analyzed by immunoblotting
with antibodies to Stx4 and pan-Cadherin as a loading control. The
relative knockdown levels of Stx4 to pan-Cadherin is quantified and
added under the blot.
Additional file 2: Figure S2. Phosphorylation of AKT in Stx4-depleted or
Stx4-overexpressed C2C12 cells. C2C12 cells were transfected with control,
Stx4, or shStx4 expression vectors, and the lysates were analyzed for the
levels of phospho-AKT (p-AKT) relative to total AKT.
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